Wang XJ - Search Results

1

"NRF2 addiction" in lung cancer cells and its impact on cancer therapy.

Hammad A, Namani A, Elshaer M, Wang XJ, Tang X. Hammad A, et al. Among authors: wang xj. Cancer Lett. 2019 Dec 28;467:40-49. doi: 10.1016/j.canlet.2019.09.016. Epub 2019 Sep 28. Cancer Lett. 2019. PMID: 31574294 Review.

2

Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.

Wang XJ, Hayes JD, Wolf CR. Wang XJ, et al. Cancer Res. 2006 Nov 15;66(22):10983-94. doi: 10.1158/0008-5472.CAN-06-2298. Cancer Res. 2006. PMID: 17108137

3

[Down-regulation of Nrf2-ARE signaling pathway].

Wang XJ, Wu JG, Tang XW. Wang XJ, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Jan;39(1):1-5. doi: 10.3785/j.issn.1008-9292.2010.01.001. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20175228 Chinese. No abstract available.

4

[Nrf2 down-regulated cell line H460-N5 with Keap1 over-expression increased sensitivity to anti-cancer drugs].

Qu LY, Gao P, Wang HY, Wang XJ, Tang XW. Qu LY, et al. Among authors: wang xj, wang hy. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Jan;39(1):6-10. doi: 10.3785/j.issn.1008-9292.2010.01.002. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20175229 Chinese.

5

Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.

Tang X, Wang H, Fan L, Wu X, Xin A, Ren H, Wang XJ. Tang X, et al. Among authors: wang h, wang xj. Free Radic Biol Med. 2011 Jun 1;50(11):1599-609. doi: 10.1016/j.freeradbiomed.2011.03.008. Epub 2011 Mar 12. Free Radic Biol Med. 2011. PMID: 21402146

6

[Nrf2 as a chemoprevention target in gastrointestinal carcinoma].

Gao P, Tang XW, Wang XJ. Gao P, et al. Among authors: wang xj. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Jul;41(4):453-63. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22927084 Review. Chinese.

7

RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2.

Wang H, Liu K, Geng M, Gao P, Wu X, Hai Y, Li Y, Li Y, Luo L, Hayes JD, Wang XJ, Tang X. Wang H, et al. Among authors: wang xj. Cancer Res. 2013 May 15;73(10):3097-108. doi: 10.1158/0008-5472.CAN-12-3386. Epub 2013 Apr 23. Cancer Res. 2013. PMID: 23612120

8

Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.

Wang XJ, Li Y, Luo L, Wang H, Chi Z, Xin A, Li X, Wu J, Tang X. Wang XJ, et al. Among authors: wang h. Free Radic Biol Med. 2014 May;70:68-77. doi: 10.1016/j.freeradbiomed.2014.02.010. Epub 2014 Feb 18. Free Radic Biol Med. 2014. PMID: 24556415

9

Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.

Chian S, Thapa R, Chi Z, Wang XJ, Tang X. Chian S, et al. Among authors: wang xj. Biochem Biophys Res Commun. 2014 May 16;447(4):602-8. doi: 10.1016/j.bbrc.2014.04.039. Epub 2014 Apr 18. Biochem Biophys Res Commun. 2014. PMID: 24747074

10

Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.

Chian S, Li YY, Wang XJ, Tang XW. Chian S, et al. Among authors: wang xj. Asian Pac J Cancer Prev. 2014;15(6):2911-6. doi: 10.7314/apjcp.2014.15.6.2911. Asian Pac J Cancer Prev. 2014. PMID: 24761924 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,437 results

Search Page

Filters